283 related articles for article (PubMed ID: 3290257)
1. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
Efendic S; Karlander S; Vranic M
J Clin Invest; 1988 Jun; 81(6):1953-61. PubMed ID: 3290257
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone increases glucose cycling, but not glucose production, in healthy subjects.
Wajngot A; Khan A; Giacca A; Vranic M; Efendic S
Am J Physiol; 1990 Nov; 259(5 Pt 1):E626-32. PubMed ID: 2240201
[TBL] [Abstract][Full Text] [Related]
3. Glucose turnover in hyperthyroid patients with normal glucose tolerance.
Karlander SG; Khan A; Wajngot A; Torring O; Vranic M; Efendić S
J Clin Endocrinol Metab; 1989 Apr; 68(4):780-6. PubMed ID: 2537842
[TBL] [Abstract][Full Text] [Related]
4. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.
Barzilai N; Hawkins M; Angelov I; Hu M; Rossetti L
Diabetes; 1996 Oct; 45(10):1329-35. PubMed ID: 8826967
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
[TBL] [Abstract][Full Text] [Related]
6. Assessment of hepatic insulin action in obese type 2 diabetic patients.
Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
[TBL] [Abstract][Full Text] [Related]
7. Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes.
Efendić S; Wajngot A; Vranić M
Proc Natl Acad Sci U S A; 1985 May; 82(9):2965-9. PubMed ID: 3857627
[TBL] [Abstract][Full Text] [Related]
8. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
Rossetti L; Giaccari A; Barzilai N; Howard K; Sebel G; Hu M
J Clin Invest; 1993 Sep; 92(3):1126-34. PubMed ID: 8397219
[TBL] [Abstract][Full Text] [Related]
9. New probes to study insulin resistance in men; futile cycle and glucose turnover.
Vranic M; Wajngot A; Efendic S
Adv Exp Med Biol; 1985; 189():227-45. PubMed ID: 3898764
[TBL] [Abstract][Full Text] [Related]
10. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
[TBL] [Abstract][Full Text] [Related]
11. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
[TBL] [Abstract][Full Text] [Related]
12. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
Mevorach M; Giacca A; Aharon Y; Hawkins M; Shamoon H; Rossetti L
J Clin Invest; 1998 Aug; 102(4):744-53. PubMed ID: 9710443
[TBL] [Abstract][Full Text] [Related]
13. Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia.
Giacca A; Groenewoud Y; Tsui E; McClean P; Zinman B
Diabetes; 1998 Nov; 47(11):1763-70. PubMed ID: 9792546
[TBL] [Abstract][Full Text] [Related]
14. Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus.
Wahren J; Felig P; Cerasi E; Luft R
J Clin Invest; 1972 Jul; 51(7):1870-8. PubMed ID: 5032528
[TBL] [Abstract][Full Text] [Related]
15. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
16. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
17. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
Gastaldelli A; Baldi S; Pettiti M; Toschi E; Camastra S; Natali A; Landau BR; Ferrannini E
Diabetes; 2000 Aug; 49(8):1367-73. PubMed ID: 10923639
[TBL] [Abstract][Full Text] [Related]
18. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
[TBL] [Abstract][Full Text] [Related]
19. Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.
Pisu E; Lombardi A; De Benedictis D; Bozzo C; Chiara E; Baggiore C; Bruno A; Cravero L; Pagano G; Lenti G
Acta Diabetol Lat; 1986; 23(3):215-25. PubMed ID: 3538736
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
